These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36028086)

  • 1. Clinical azole cross-resistance in Candida parapsilosis is related to a novel MRR1 gain-of-function mutation.
    Branco J; Ryan AP; Pinto E Silva A; Butler G; Miranda IM; Rodrigues AG
    Clin Microbiol Infect; 2022 Dec; 28(12):1655.e5-1655.e8. PubMed ID: 36028086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering the Mrr1/Mdr1 Pathway in Azole Resistance of Candida auris.
    Li J; Coste AT; Bachmann D; Sanglard D; Lamoth F
    Antimicrob Agents Chemother; 2022 Apr; 66(4):e0006722. PubMed ID: 35343781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
    Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA
    Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species distribution, azole resistance and related molecular mechanisms in invasive Candida parapsilosis complex isolates: Increase in fluconazole resistance in 21 years.
    Demirci-Duarte S; Arikan-Akdagli S; Gülmez D
    Mycoses; 2021 Aug; 64(8):823-830. PubMed ID: 33934400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upc2-mediated mechanisms of azole resistance in
    Li J; Aubry L; Brandalise D; Coste AT; Sanglard D; Lamoth F
    Microbiol Spectr; 2024 Feb; 12(2):e0352623. PubMed ID: 38206035
    [No Abstract]   [Full Text] [Related]  

  • 6. Transcriptional profiling of azole-resistant Candida parapsilosis strains.
    Silva AP; Miranda IM; Guida A; Synnott J; Rocha R; Silva R; Amorim A; Pina-Vaz C; Butler G; Rodrigues AG
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3546-56. PubMed ID: 21518843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals.
    Eddouzi J; Parker JE; Vale-Silva LA; Coste A; Ischer F; Kelly S; Manai M; Sanglard D
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3182-93. PubMed ID: 23629718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluconazole-resistant Candida parapsilosis strains with a Y132F substitution in the ERG11 gene causing invasive infections in a neonatal unit, South Africa.
    Magobo RE; Lockhart SR; Govender NP
    Mycoses; 2020 May; 63(5):471-477. PubMed ID: 32124485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virulence factors, antifungal susceptibility and molecular mechanisms of azole resistance among Candida parapsilosis complex isolates recovered from clinical specimens.
    Neji S; Hadrich I; Trabelsi H; Abbes S; Cheikhrouhou F; Sellami H; Makni F; Ayadi A
    J Biomed Sci; 2017 Sep; 24(1):67. PubMed ID: 28870262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triazole Evolution of Candida parapsilosis Results in Cross-Resistance to Other Antifungal Drugs, Influences Stress Responses, and Alters Virulence in an Antifungal Drug-Dependent Manner.
    Papp C; Bohner F; Kocsis K; Varga M; Szekeres A; Bodai L; Willis JR; Gabaldón T; Tóth R; Nosanchuk JD; Vágvölgyi C; Gácser A
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33115837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of ERG3 mutations and expression of ergosterol genes controlled by UPC2 and NDT80 in Candida parapsilosis azole resistance.
    Branco J; Ola M; Silva RM; Fonseca E; Gomes NC; Martins-Cruz C; Silva AP; Silva-Dias A; Pina-Vaz C; Erraught C; Brennan L; Rodrigues AG; Butler G; Miranda IM
    Clin Microbiol Infect; 2017 Aug; 23(8):575.e1-575.e8. PubMed ID: 28196695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candida parapsilosis Mdr1B and Cdr1B Are Drivers of Mrr1-Mediated Clinical Fluconazole Resistance.
    Doorley LA; Rybak JM; Berkow EL; Zhang Q; Morschhäuser J; Rogers PD
    Antimicrob Agents Chemother; 2022 Jul; 66(7):e0028922. PubMed ID: 35699442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gain-of-function mutations in the transcription factor MRR1 are responsible for overexpression of the MDR1 efflux pump in fluconazole-resistant Candida dubliniensis strains.
    Schubert S; Rogers PD; Morschhäuser J
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4274-80. PubMed ID: 18809934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and Molecular Basis of Resistance to Fluconazole Among Clinical Candida parapsilosis Isolates in Kuwait.
    Asadzadeh M; Ahmad S; Al-Sweih N; Khan Z
    Microb Drug Resist; 2017 Dec; 23(8):966-972. PubMed ID: 28353392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of clonal fluconazole-resistant Candida parapsilosis clinical isolates in a multicentre laboratory-based surveillance study in India.
    Singh A; Singh PK; de Groot T; Kumar A; Mathur P; Tarai B; Sachdeva N; Upadhyaya G; Sarma S; Meis JF; Chowdhary A
    J Antimicrob Chemother; 2019 May; 74(5):1260-1268. PubMed ID: 30753525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of fluconazole resistance in Candida parapsilosis isolates from a U.S. surveillance system.
    Grossman NT; Pham CD; Cleveland AA; Lockhart SR
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1030-7. PubMed ID: 25451046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of C-5 Sterol Desaturase Activity Results in Increased Resistance to Azole and Echinocandin Antifungals in a Clinical Isolate of Candida parapsilosis.
    Rybak JM; Dickens CM; Parker JE; Caudle KE; Manigaba K; Whaley SG; Nishimoto AT; Luna-Tapia A; Roy S; Zhang Q; Barker KS; Palmer GE; Sutter TR; Homayouni R; Wiederhold NP; Kelly SL; Rogers PD
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candida albicans Swi/Snf and Mediator Complexes Differentially Regulate Mrr1-Induced
    Liu Z; Myers LC
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug Transporters and Alterations in Sterol Biosynthesis Contribute to Azole Antifungal Resistance in Candida parapsilosis.
    Berkow EL; Manigaba K; Parker JE; Barker KS; Kelly SL; Rogers PD
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5942-50. PubMed ID: 26169412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.